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Background: Severe cardiac conduction disturbances requiring permanent pacemaker
implantation (PPI) are frequent complications following transcatheter aortic valve
implantation (TAVI). There is only limited information available about the prognostic
impact of this complication.
Methods: 960 patients with severe symptomatic aortic stenosis underwent TAVI in 3
tertiary centers. Both the balloon-expandable Edwards-Sapien valve (ES) (672, 70%) and
the self-expanding Medtronic CoreValve (MCV) (288, 30%) were used.
Results: 51 patients treated with the ES (7.6%) and 61 with the MCV (21.2%) required
a PPI (p0.0001). Patients who needed a PPI had a larger prosthesis diameter (26.92.1
vs. 26.02.3mm, p0.0001) and transfemoral approach was more frequently used (78.3
vs. 69.0%, p0.049). The other demographic and procedural characteristics did not differ
(similar age 836.3 years and logistic Euroscore 22.911.1%). Hospital stay was
increased in patients with PPI (12.27.0 vs. 10.58.0 days, p0.032) but 30-day
survival was similar in the global cohort (91.1 vs. 89.4%, p0.578), with the ES (90.2 vs.
88.5%, p0.718) or the MCV (91.8 vs. 91.6%, p0.965). The one-year survival rate was
lower in patients who needed a PPI compared to those who did not, but the difference was
not significant (55.3 vs. 60.9%, p0.456). This holds true for both types of valve (ES 54.5
vs. 61%, p0.544; MCV 56 vs. 60.4%, p0.688).
Conclusions: In this large observational study, PPI after TAVI did not negatively impact
early and mid-term survival in patients treated with either the ES or MCV prosthesis.
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Background: The nature of paravalvular leaks after transcatheter aortic valve implan-
tation (TAVI) is not fully understood. Aortic annular or valvular calcification may be
causative. Objective was to quantify and characterize aortic valve leaflet and annular
calcification with computed tomography angiography (CTA) and define whether they
predict leaks.
Methods: 56 patients (age 83.1y5.4) with severe aortic stenosis underwent CTA prior
to TAVI: 1)Annular calcification were measured in 2 planes and characterized as
“protruding”, “round” and “adherent” for the non-coronary (NC), right-coronary (RC) and
left-coronary (LC). 2)Leaflet calcification were scored regarding severity (S) (grade 1-4),
and total S-, asymmetry (A-) and combined A/S-score calculated. 3) Annulus eccentricity
index was calculated. Transthoracic echocardiography was performed after, at 1 month, 3,
6, 12, and 24 months after TAVI.
Results: 41 patients had no or mild (AR grade I) and 15 patients “relevant”
(moderate-to-severe paravalvular leaks AR1.5). “Protruding annular calcification
(PAC)4mm or adherent annular calcification 6mm” predicted relevant leaks
(p0.01). Total and LC-annulus calcium size was higher in relevant leaks (p0.03 and
p0.009, resp.) and an increasing size was the strongest predictor (p0.001). Total
LC/NC- and LC-Calcium size score predicted relevant leaks (p0.004 and p 0.001,
resp.) but not RC or NC. There was a tendency towards higher total S- and A/S- scores
with increasing leak severity with a weak correlation (r0.29, p0.02) for S-score, while
A-score was not. Annulus eccentricity did not predict relevant leaks.
Conclusions: Protruding annular calcification4mm and adherent calcification6mm;
particularly left-sided, predict relevant paravalvular leaks after TAVI. Increasing annular
calcium size is another major predictor, while leaflet calcification severity, asymmetry and
annulus eccentricity were not associated.
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Background: Outcomes of postdilatation should be properly analysed in patients
undergoing TAVI. Hereby, results and complications of postdilatation in patients with
residual significant AR using both the Edwards and CoreValve systems are discussed
thoroughly.
Methods: From November 2007 to December 2011, 384 patients underwent TAVI in our
center [233 Edwards and 151 CoreValve]. 74 were treated with postdilatation for residual
AR following valve implantation. In this study, 68 were analyzed after excluding 6
patients due to unavailable data.
Results: Mean age was 796.2 yrs and 42 (61.7%) were males. Mean logistic Euroscore
and STS score were 25.217.3 and 9.19.1, respectively. Mean grades of aortic
regurgitation at baseline, before and after postdilatation were 1.31.1, 2.30.7 and
0.80.6, respectively. Edwards valve was used in 13 (19.1%), while CoreValve in 55
(80.8%). Mean valve size was 27.12.2 mm. Mean balloon size was 25.62.3mm. Mean
valve size/annulus diameter was 1.10.1, mean balloon diameter/valve size was 0.90.1.
In 51 patients (75% of the ones who had postdilatation), postdilatation was effective in
minimizing AR by at least 1 grade. A second valve was needed in 5 (7.4%) with residual
significant AR after postdilatation. Overall, postdilatation was associated with complica-
tions in 4 (5.9%): coronary obstruction occurred in 1(1.5%) with Edwards valve, LM
dissection in 1 patient (1.5%) with Edwards valve, annular tear in 1 patient (1.5%) with
Edwards valve, and valve embolization in 1(1.5%) with CoreValve. Two patients (3%)
had AR2 at the end of the procedure. At 30-days echocardiographic follow-up showed
grade 1.20.9 AR. The effectiveness of postdilatation for both Edwards and CoreValve
were similar (77% & 83% respectively, p0.6).
Conclusions: Postdilatation appears to be effective in reducing residual AR following
implantation of both Edwards and CoreValve. However, postdilatation may be rarely
associated with significant complications and thus correct patient and balloon size
selection are essential.
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Background: Vascular access complications during Transcatheter Aortic Valve Implan-
tation (TAVI) have been associated with significant increase of morbidity and mortality.
The need for establishment of reliable predictors for these serious events remains pivotal.
The origin and course of inferior epigastric artery reliably defines the borders of inguinal
ligament. We hypothesize that we can reduce vascular access site complications during
TAVI, by using the course of inferior epigastric artery as a landmark for the upper safe
margin for femoral puncture.
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